Update on Immune Checkpoint Inhibitor Enterocolitis

PURPOSE OF REVIEW: Immune checkpoint inhibitor (ICI) therapy revolutionized the treatment of multiple solid and hematologic malignancies. Yet, with it came profound inflammatory toxicities that mimic autoimmune diseases, termed immune-related adverse events (irAEs). Prominent among these is gastroin...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly-Goss, Molly R., Badran, Yousef R., Dougan, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Inflammatory Bowel Disease (B Cohen, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583048/
https://www.ncbi.nlm.nih.gov/pubmed/36264425
http://dx.doi.org/10.1007/s11894-022-00852-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583048/
https://www.ncbi.nlm.nih.gov/pubmed/36264425
http://dx.doi.org/10.1007/s11894-022-00852-7

Ejemplares similares